Table 1 List of sense-AFAS probe pairs detecting altered expression balances in normal tissue and cancer tissue in patients with colon cancer based on the random priming approach
AFAS ID | Diff. (%) | Annotation |
|---|---|---|
X07876-03 | 97.2 | wingless-type MMTV integration site family member 2 |
L31951-03 | 94.1 | mitogen-activated protein kinase 9 |
U29343-04 | 74.6 | hyaluronan-mediated motility receptor (RHAMM) |
U09304-01 | 63.3 | ephrin-B1 |
U43746-02 | 62.6 | breast cancer 2, early onset |
X63629-03 | 57.8 | cadherin 3, type 1, P-cadherin (placental) |
M25753-01 | 54.5 | cyclin B1 |
U69611-04 | 50.7 | a disintegrin and metalloproteinase domain 17 (tumor necrosis factor, alpha, converting enzyme) |
M63167-01 | 47.9 | v-akt murine thymoma viral oncogene homolog 1 |
M77830-02 | 43.9 | desmoplakin (DPI, DPII) |
M29366-04 | 40.9 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) |
M15990-01 | 39.3 | v-yes-1 Yamaguchi sarcoma viral oncogene homolog 1 |
X53586-04 | 38.4 | integrin, alpha 6 |
U43746-15 | 37.1 | breast cancer 2, early onset |
J04088-07 | 36.5 | topoisomerase (DNA) II alpha (170 kD) |
X87852-02 | 36.5 | plexin A3 |
X05232-03 | 32.7 | matrix metalloproteinase 3 (stromelysin 1, progelatinase) |
M29039-02 | 32.7 | jun B proto-oncogene |
X80343-01 | 32.4 | cyclin-dependent kinase 5, regulatory subunit 1 (p35) |
L34058-01 | 30.3 | cadherin 13, H-cadherin (heart) |
Y10479-01 | 30.3 | E2F transcription factor 3 |
M14505-02 | 29.7 | cyclin-dependent kinase 4 |
J02958-06 | 29.7 | met proto-oncogene (hepatocyte growth factor receptor) |
U43746-11 | 29.1 | breast cancer 2, early onset |
U58334-01 | 29.1 | tumor protein p53 binding protein, 2 |
X63629-01 | 28.5 | cadherin 3, type 1, P-cadherin (placental) |
U58334-02 | 28.2 | tumor protein p53 binding protein, 2 |
X56654-01 | 27.9 | desmoglein 1 |
M81934-01 | 27.6 | cell division cycle 25B |
X66363-03 | 27.6 | PCTAIRE protein kinase 1 |
M26880-04 | 26.8 | ubiquitin C |
U37139-02 | 25.6 | integrin beta 3 binding protein (beta3-endonexin) |
L29222-02 | 24.2 | CDC-like kinase 1 |
U01038-02 | 21.9 | polo-like kinase (Drosophila) |
M35410-02 | 21.1 | insulin-like growth factor binding protein 2 (36 kD) |
M35296-07 | 18.9 | v-abl Abelson murine leukemia viral oncogene homolog 2 (arg, Abelson-related gene) |
AF022385-02 | 18.6 | programmed cell death 10 |
M30704-01 | 17.5 | amphiregulin (schwannoma-derived growth factor) |
U43142-01 | 16.1 | vascular endothelial growth factor C |
M32315-05 | 15.9 | tumor necrosis factor receptor superfamily, member 1B |
M85289-12 | 15.9 | heparan sulfate proteoglycan 2 (perlecan) |
AB000220-03 | 13.5 | sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C |
U29343-01 | 11.2 | hyaluronan-mediated motility receptor (RHAMM) |
NM_005417-02 | 10.7 | v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) |
U16752-04 | 70.2 | stromal cell-derived factor 1 |
D21337-07 | 35.2 | collagen, type IV, alpha 6 |
Y00815-03 | 16.9 | protein tyrosine phosphatase, receptor type, F |
X04571-05 | 13.8 | epidermal growth factor (beta-urogastrone) |
L12002-06 | 10.9 | integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor) |